Definitive quantification of apolipoprotein a-I by isotope ditutioa FAB mass spectrometry

1994 ◽  
Vol 108 ◽  
pp. S193
Author(s):  
John R. Barr ◽  
Vincent L. Maggio ◽  
Louis R. Alexander ◽  
Donald G. Panerson ◽  
L.Omar Henderson ◽  
...  
1993 ◽  
Vol 115 (16) ◽  
pp. 7381-7388 ◽  
Author(s):  
Masami Sawada ◽  
Yasuo Okumura ◽  
Motohiro Shizuma ◽  
Yoshio Takai ◽  
Yukio Hidaka ◽  
...  

2020 ◽  
Author(s):  
Sandra Goetze ◽  
Kathrin Frey ◽  
Lucia Rohrer ◽  
Silvija Radosavljevic ◽  
Jan Krützfeldt ◽  
...  

AbstractBackgroundHigh-density lipoprotein (HDL) is a heterogenous mixture of blood-circulating multimolecular particles containing many different proteins, lipids, and RNAs. Recent advancements in mass spectrometry-based proteotype analysis strategies enable the sensitive and reproducible quantification of proteins across large patient cohorts.MethodsHDL particles were isolated from plasma of more than 300 healthy individuals or patients with a multiplicity of physiological HDL states. From these, peptides were extracted and HDL proteome spectral libraries were generated. This is a prerequisite for using data-independent acquisition (DIA) strategies to analyze HDL particles from clinical cohorts using mass spectrometry.ResultsThe resulting HDL proteome spectral libraries consist of 296 protein groups and 341 peptidoforms of potential biological significance identified with high confidence. We used the HDL proteome libraries to evaluate HDL proteotype differences in between healthy individuals and patients suffering from diabetes mellitus type 2 (T2DM) and/or coronary heart disease (CHD). Bioinformatic interrogation of the data revealed significant quantitative differences in the HDL proteotypes including a significant depletion of phosphatidylinositol-glycan-specific phospholipase D (PHLD) from disease-derived HDL particles.ConclusionThe DIA-based HDL proteotyping strategy enabled sensitive and reproducible digitization of HDL proteotypes derived from patient cohorts and provides new insights into the composition of HDL particles as a rational basis to decode structure-function-disease relationships of HDL.List of human genes and protein names discussed in the paper- APOA1 (Apolipoprotein A-I)- APOA2 (Apolipoprotein A-II)- APOE (Apolipoprotein E)- APOC3 (Apolipoprotein C3)- CLUS (Clusterin)- PHLD (Phosphatidylinositol-glycan-specific phospholipase D)- PON1 (Serum paraoxonase/arylesterase 1)- PON3 (Serum paraoxonase/lactonase 3)- PSPB (Pulmonary surfactant-associated protein B)- RAB1B (Ras-related protein Rab-1B)- RAB6A (Ras-related protein Rab-6A)- RB11A/B (Ras-related protein Rab-11A/B)- RP1BL (Ras-related protein Rap-1b-like protein)- RAB10 (Ras-related protein Rab-10)- SAA1 (Serum amyloid A-1 protein)- SAA2 (Serum amyloid A-2 protein)- SAA4 (Serum amyloid A-4 protein)- SCRB1 (Scavenger receptor class B member 1)


1983 ◽  
Vol 48 (24) ◽  
pp. 4445-4449 ◽  
Author(s):  
John M. Wasylyk ◽  
Joseph E. Biskupiak ◽  
Catherine E. Costello ◽  
Chris M. Ireland

1994 ◽  
Vol 72 (1) ◽  
pp. 164-169 ◽  
Author(s):  
Yimin Zhao ◽  
Martina Michenfelder ◽  
János Rétey

We describe the synthesis of three novel analogues of propionyl-coenzyme A, in which the sulfur atom has been replaced by methylene, ethylene, and thiomethylene, respectively. All three analogues, propionyl-dethia(carba)-CoA (1), propionyl-dethia(dicarba)-CoA (2), and S-(2-oxobutanyl)-CoA (3) were characterized by 1H and 31P NMR spectroscopy and FAB mass spectrometry. Propionyl-CoA–oxaloacetate transcarboxylase from Propionibacterium shermanii accepted the novel analogues as substrates and carboxylated them to the corresponding methylmalonyl-CoA analogues (4–6). The latter were further converted into the succinyl-CoA analogues by the coenzyme-B12-dependent methylmalonyl-CoA mutase from the same organism. The succinyl-CoA analogues, succinyl-dethia(carba)-CoA (7), succinyl-dethia(dicarba)-CoA (8), and 4-carboxy(2-oxobutanyl)-CoA (9) were obtained on a preparative scale and their Michaelis constants (Km) with methylmalonyl-CoA mutase were determined to be 0.136, 2.20, and 0.132 mM, respectively (Km for succinyl-CoA is 0.025 mM). The Vmax values for 7, 8, and 9 are 1.1, 0.013, and 0.0047 µmol min−1 U−1, respectively (Vmax for succinyl CoA is 1.0). The utility of the novel coenzyme A analogues in enzyme mechanistic studies is discussed.


Sign in / Sign up

Export Citation Format

Share Document